T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Roper Technologies
ROP
|
+$840M |
| 2 |
Cigna
CI
|
+$836M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$788M |
| 4 |
Abbott
ABT
|
+$766M |
| 5 |
Becton Dickinson
BDX
|
+$743M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$1.26B |
| 2 |
Martin Marietta Materials
MLM
|
+$1.05B |
| 3 |
Linde
LIN
|
+$913M |
| 4 |
Intercontinental Exchange
ICE
|
+$865M |
| 5 |
AbbVie
ABBV
|
+$857M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.45% |
| 2 | Healthcare | 20.82% |
| 3 | Consumer Discretionary | 13.33% |
| 4 | Industrials | 10.66% |
| 5 | Financials | 10.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Meritage Homes
MTH
$4.8B
| $80.7M | 0.05% |
1,048,636
-649,580
| -38% | -$59.3M |
|
327
MYR Group
MYRG
$5.2B
| $79.9M | 0.05% |
537,347
+159,302
| +42% | +$22.3M |
|
328
Vertex
VERX
$2.02B
| $79.5M | 0.05% |
1,490,385
+423,007
| +40% | +$20.5M |
|
329
Procept Biorobotics
PRCT
$1.26B
| $79.4M | 0.05% |
985,942
-45,785
| -4% | -$3.91M |
|
|
SAFE
330
Safehold
SAFE
$1.1B
| $78.8M | 0.05% |
4,266,769
+336,458
| +9% | +$7.31M |
|
331
Endava
DAVA
$163M
| $78.8M | 0.05% |
2,549,317
+171,048
| +7% | +$4.68M |
|
332
DT Midstream
DTM
$13.8B
| $78.2M | 0.05% |
786,387
-73,114
| -9% | -$6.96M |
|
333
HealthEquity
HQY
$8.75B
| $78.1M | 0.05% |
+814,034
| New | +$75.9M |
|
334
Middlesex Water
MSEX
$1.11B
| $77.4M | 0.05% |
1,471,404
+126,732
| +9% | +$7.96M |
|
|
BWIN
335
Baldwin Insurance Group
BWIN
$2.93B
| $77.3M | 0.05% |
1,993,871
+1,110,444
| +126% | +$51.8M |
|
336
SLM Corp
SLM
$5.21B
| $76.4M | 0.05% |
+2,768,741
| New | +$68.5M |
|
337
Immatics
IMTX
$1.32B
| $75.4M | 0.05% |
10,604,777
+3,225,141
| +44% | +$27.7M |
|
338
Brady Corp
BRC
$4.44B
| $75.2M | 0.05% |
1,017,797
-703,845
| -41% | -$52.3M |
|
|
PMT
339
PennyMac Mortgage Investment
PMT
$836M
| $74M | 0.05% |
5,874,618
+7,254
| +0.1% | +$98.1K |
|
340
Privia Health
PRVA
$2.75B
| $73.8M | 0.05% |
3,774,756
-1,661,338
| -31% | -$32.9M |
|
341
Marqeta
MQ
$1.66B
| $72.9M | 0.05% |
+4,807,263
| New | +$84.4M |
|
342
Stevanato
STVN
$5.83B
| $72M | 0.04% |
3,304,992
-437,734
| -12% | -$8.77M |
|
|
SEI
343
Solaris Energy Infrastructure
SEI
$4.07B
| $71.6M | 0.04% |
+2,488,143
| New | +$49.5M |
|
344
Nomad Foods
NOMD
$1.64B
| $70.1M | 0.04% |
4,176,211
+86,897
| +2% | +$1.52M |
|
345
Marriott Vacations Worldwide
VAC
$4.14B
| $69.9M | 0.04% |
778,684
+7,046
| +0.9% | +$610K |
|
346
Zurn Elkay Water Solutions
ZWS
$8.41B
| $69.7M | 0.04% |
1,869,345
-1,402,349
| -43% | -$53.5M |
|
347
Globant
GLOB
$1.71B
| $67.8M | 0.04% |
316,183
+74,447
| +31% | +$16.2M |
|
348
Encore Capital Group
ECPG
$2.14B
| $67.7M | 0.04% |
1,416,499
+327,637
| +30% | +$15.5M |
|
|
HONE
349
DELISTED
HarborOne Bancorp
HONE
| $67.3M | 0.04% |
5,693,131
+131,602
| +2% | +$1.67M |
|
350
Monro
MNRO
$364M
| $67M | 0.04% |
2,702,250
+85,378
| +3% | +$2.34M |
|
Similar funds
T. Rowe Price Investment Management's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Investment Management held 684 positions worth $162B, down 2.2% from $166B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Investment Management's Q4 2024 filing shows 61 new, 276 increased, 294 reduced and 51 closed positions. Its largest new stake was Cigna: 2,623,729 shares worth $725M. The largest sale was Salesforce, an estimated $1.26B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Investment Management's largest Q4 2024 buy was Cigna: 2,623,729 shares worth $725M.
- T. Rowe Price Investment Management added most to Roper Technologies in Q4 2024, an estimated $840M increase.
- T. Rowe Price Investment Management's biggest Q4 2024 reduction was Salesforce, cutting an estimated $1.26B.
- T. Rowe Price Investment Management fully exited Southwestern Energy Company in Q4 2024, selling an estimated $278M.
- T. Rowe Price Investment Management's ten largest holdings make up 19% of its $162B portfolio in Q4 2024.
- T. Rowe Price Investment Management opened 61 new positions and closed 51 in Q4 2024.
- T. Rowe Price Investment Management's portfolio value fell 2.2% quarter-over-quarter to $162B.
Based on T. Rowe Price Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.